http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8100516-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bdb8f88ed9ace594807b1a364fa173c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00377
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
filingDate 1980-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca91e53d9c4122e44cff336111d08236
publicationDate 1981-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8100516-A1
titleOfInvention Gel containing fibrine and antibiotic for treating infected bones and preparation process thereof
abstract A gel based on fibrine and antibiotic for the treatment of an infected bone contains fibrinogene, a solution containing thrombin and enriched with calcium ions as well as an antibiotic of the tobramycin, gentiamycin group and/or one of their physiologically acceptable salts. The gel may be prepared by mixing the fibrinogene in the form of a lyophilisate or cryoprecipitate with an antibiotic in sterile conditions and then adding a thrombin solution enriched with calcium ions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022242533-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7597687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0197872-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9131929-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8419722-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7189410-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39321-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39298-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529961-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8529960-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6559119-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39192-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6921532-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7208179-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2510408-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8679528-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6117425-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2001273623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6762336-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8986304-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6197325-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7229959-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6468527-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009014776-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8403923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6054122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911789-B2
priorityDate 1979-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2385802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2651441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2852319-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2511122-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3723244-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127708637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136214625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395180

Total number of triples: 74.